A randomized, open-label, multi-center phase III trial comparing tisagenlecleucel to standard of care in adult participants with relapsed or refractory follicular lymphoma

  • Inam, Shafqat (Primary Chief Investigator (PCI))
  • Malherbe, Maturos (Project Manager)
  • Opat, Stephen (Chief Investigator (CI))
  • Ho, Phoebe Joy (Chief Investigator (CI))
  • Cheah, Chan (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date10/08/23 → 9/08/25

Keywords

  • Clinical trial
  • CCTL019E2301